Topical Therapy in Atopic Dermatitis Patient
Background: Atopic dermatitis (AD) is an inflammation skin disorder characterized by itchy, chronic, residif, can occur in infant, child, and adult. The therapy for AD are divided into systemic and topical therapy. Topical therapy is the first line therapy for mild and moderate AD which are the most...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Indonesian |
| Published: |
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga
2017-01-01
|
| Series: | Berkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology) |
| Subjects: | |
| Online Access: | https://e-journal.unair.ac.id/BIKK/article/view/3463 |
| _version_ | 1827673669136023552 |
|---|---|
| author | Wahyunita Desi Ratnaningtyas Marsudi Hutomo |
| author_facet | Wahyunita Desi Ratnaningtyas Marsudi Hutomo |
| author_sort | Wahyunita Desi Ratnaningtyas |
| collection | DOAJ |
| description | Background: Atopic dermatitis (AD) is an inflammation skin disorder characterized by itchy, chronic, residif, can occur in infant, child, and adult. The therapy for AD are divided into systemic and topical therapy. Topical therapy is the first line therapy for mild and moderate AD which are the most common type AD. Purpose: To evaluate the pattern of topical therapy in new AD patients. Methods: Retrospective study methods was performed by evaluating medical records of new AD patients who received topical therapy in Allergy Immunology Division, Department of Dermatology and Venereology, Dr. Soetomo General Hospital from 2013 until 2015. The evaluated data included the patient's visitation, age, gender, time visit, patient's complaint, periode of illness, history of atopy, physical examination, management, and follow up. Results: There were 272 patients (83.2%) of 327 new AD patients who received topical therapy. Topical therapies were provided in form of corticosteroid topical for 187 patients (23.6%), emolient for 183 patients (23.1%), and topical antibiotic for 40 patients (5.1%). Patients who did not return to the hospital after first visitation were 174 patients (53.2%). Conclusion: Corticosteroid topical is the first line therapy for atopic dermatitis, but emolient is important to improve skin barrier. |
| first_indexed | 2024-03-10T04:27:56Z |
| format | Article |
| id | doaj.art-8fc5c76360e74ec38b9df36c5cbca9d0 |
| institution | Directory Open Access Journal |
| issn | 1978-4279 2549-4082 |
| language | Indonesian |
| last_indexed | 2024-03-10T04:27:56Z |
| publishDate | 2017-01-01 |
| publisher | Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga |
| record_format | Article |
| series | Berkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology) |
| spelling | doaj.art-8fc5c76360e74ec38b9df36c5cbca9d02023-11-23T06:27:40ZindDepartment of Dermatology and Venereology, Faculty of Medicine, Universitas AirlanggaBerkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology)1978-42792549-40822017-01-0128321021610.20473/bikk.V28.3.2016.210-2162740Topical Therapy in Atopic Dermatitis PatientWahyunita Desi Ratnaningtyas0Marsudi Hutomo1Departemen/Staf Medik Fungsional Ilmu Kesehatan Kulit dan Kelamin Fakultas Kedokteran Universitas Airlangga/Rumah Sakit Umum Daerah Dr. Soetomo SurabayaDepartemen/Staf Medik Fungsional Ilmu Kesehatan Kulit dan Kelamin Fakultas Kedokteran Universitas Airlangga/Rumah Sakit Umum Daerah Dr. Soetomo SurabayaBackground: Atopic dermatitis (AD) is an inflammation skin disorder characterized by itchy, chronic, residif, can occur in infant, child, and adult. The therapy for AD are divided into systemic and topical therapy. Topical therapy is the first line therapy for mild and moderate AD which are the most common type AD. Purpose: To evaluate the pattern of topical therapy in new AD patients. Methods: Retrospective study methods was performed by evaluating medical records of new AD patients who received topical therapy in Allergy Immunology Division, Department of Dermatology and Venereology, Dr. Soetomo General Hospital from 2013 until 2015. The evaluated data included the patient's visitation, age, gender, time visit, patient's complaint, periode of illness, history of atopy, physical examination, management, and follow up. Results: There were 272 patients (83.2%) of 327 new AD patients who received topical therapy. Topical therapies were provided in form of corticosteroid topical for 187 patients (23.6%), emolient for 183 patients (23.1%), and topical antibiotic for 40 patients (5.1%). Patients who did not return to the hospital after first visitation were 174 patients (53.2%). Conclusion: Corticosteroid topical is the first line therapy for atopic dermatitis, but emolient is important to improve skin barrier.https://e-journal.unair.ac.id/BIKK/article/view/3463atopic dermatitistopical therapyretrospective |
| spellingShingle | Wahyunita Desi Ratnaningtyas Marsudi Hutomo Topical Therapy in Atopic Dermatitis Patient Berkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology) atopic dermatitis topical therapy retrospective |
| title | Topical Therapy in Atopic Dermatitis Patient |
| title_full | Topical Therapy in Atopic Dermatitis Patient |
| title_fullStr | Topical Therapy in Atopic Dermatitis Patient |
| title_full_unstemmed | Topical Therapy in Atopic Dermatitis Patient |
| title_short | Topical Therapy in Atopic Dermatitis Patient |
| title_sort | topical therapy in atopic dermatitis patient |
| topic | atopic dermatitis topical therapy retrospective |
| url | https://e-journal.unair.ac.id/BIKK/article/view/3463 |
| work_keys_str_mv | AT wahyunitadesiratnaningtyas topicaltherapyinatopicdermatitispatient AT marsudihutomo topicaltherapyinatopicdermatitispatient |